BABIO Launches Enhanced Virus Transport Kit (Non‑Inactivated) for Global Diagnostic Needs

BABIO, a well‑known Chinese manufacturer of medical diagnostic reagents and sample‑collection solutions, has introduced an upgraded Virus Transport Kit (Non‑inactivated) designed to support laboratories and healthcare facilities across Europe, the United States, Africa, and Southeast Asia. As global demand for reliable viral sample collection continues to rise, BABIO’s VTM solution offers a combination of stability, safety, and performance that aligns with current high‑search trends in clinical diagnostics.

The kit features multiple fill‑volume options (1ml–6ml) and flexible packaging choices (20–500 packs), making it suitable for hospitals, reference laboratories, public‑health agencies, and point‑of‑care testing programs. Built with high‑clarity, shatter‑resistant tubes and flocking swabs with breakpoint design, the system ensures efficient specimen collection and secure transport.

BABIO’s non‑inactivated VTM uses an optimized Hank’s solution enriched with antibiotics, helping maintain viral viability while inhibiting bacterial and fungal contamination. This makes the kit compatible with downstream applications such as nucleic acid extraction, PCR‑based molecular detection, and virus isolation—a key requirement for laboratories handling respiratory viruses, emerging pathogens, and routine surveillance samples.

With a daily production capacity of approximately 100,000 units, BABIO continues to supply high‑quality VTM kits to global markets, including the U.S. and Germany. The company also offers competitive pricing and customizable OEM/ODM options for distributors and healthcare networks.

For more details about BABIO’s Virus Transport Kit (Non‑inactivated) and other diagnostic solutions, please visit the official website: https://www.babiocorp.com

#VirusTransportKit #VTM #BABIO #LaboratorySupplies #DiagnosticReagents #SampleCollection #GlobalHealthcare #PCRTesting